10nm Chips Promise Lower Costs
Handel Jones, International Business Strategies Inc.
6/15/2015 07:00 AM EDT
The challenges in the supply chain logistics for semiconductors continue to increase, but the 10nm node will give one more opportunity to gain large benefits from technology scaling.
In March 2012, International Business Strategies (IBS) projected that gate costs at 20nm and 16/14nm would be higher than previous generations of technology. The analysis of the gate cost for 10nm now exhibits a different pattern, shown in the figure below.
![]() |
E-mail This Article | ![]() |
![]() |
Printer-Friendly Page |
Related News
- Strict Restrictions Imposed by US CHIPS Act Will Lower Willingness of Multinational Suppliers to Invest; Chinese Semiconductor Development Will Be Limited for Next Decade, Says TrendForce
- Sondrel's latest reference IP platform enables ultra-powerful signal and data processing SoCs to be created faster for lower costs
- Intel Eases Use of FPGA Acceleration: Combines Platforms, Software Stack and Ecosystem Solutions to Maximize Performance and Lower Data Center Costs
- MediaTek to Stay with TSMC for Finer-Node Chips
- First IBM Technology for Power-Management Chips Holds Promise for Breakthroughs in Alternative Energy
Breaking News
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- Keysom Unveils Keysom Core Explorer V1.0
Most Popular
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- SiFive and Kinara Partner to Offer Bare Metal Access to RISC-V Vector Processors
- Imagination Announces E-Series: A New Era of On-Device AI and Graphics
- Siemens to accelerate customer time to market with advanced silicon IP through new Alphawave Semi partnership
- Cadence Unveils Millennium M2000 Supercomputer with NVIDIA Blackwell Systems to Transform AI-Driven Silicon, Systems and Drug Design